Bank of New York Mellon Corp - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 102 filers reported holding ARATANA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$874,000
+45.9%
169,284
+1.7%
0.00%
Q1 2019$599,000
-40.5%
166,455
+1.4%
0.00%
Q4 2018$1,006,000
+16.4%
164,182
+11.0%
0.00%
Q3 2018$864,000
+36.7%
147,912
-0.5%
0.00%
Q2 2018$632,000
-1.4%
148,617
+2.2%
0.00%
Q1 2018$641,000
-15.7%
145,437
+0.6%
0.00%
Q4 2017$760,000
-10.9%
144,558
+4.0%
0.00%
Q3 2017$853,000
-14.0%
139,062
+1.4%
0.00%
Q2 2017$992,000
+48.7%
137,102
+8.9%
0.00%
Q1 2017$667,000
-28.4%
125,873
-2.9%
0.00%
Q4 2016$931,000
-27.5%
129,659
-5.6%
0.00%
Q3 2016$1,285,000
+48.4%
137,301
+0.3%
0.00%
Q2 2016$866,000
+33.8%
136,864
+16.7%
0.00%
Q1 2016$647,000
-10.9%
117,274
-9.9%
0.00%
Q4 2015$726,000
-44.5%
130,092
-15.9%
0.00%
Q3 2015$1,308,000
-47.4%
154,617
-6.1%
0.00%
-100.0%
Q2 2015$2,488,000
-21.7%
164,593
-17.1%
0.00%0.0%
Q1 2015$3,178,000
-9.0%
198,492
+1.3%
0.00%0.0%
Q4 2014$3,492,000
+162.4%
196,010
+47.8%
0.00%
Q3 2014$1,331,000
-68.5%
132,589
-51.0%
0.00%
-100.0%
Q2 2014$4,226,000
+178.2%
270,790
+230.9%
0.00%
Q1 2014$1,519,000
+157.9%
81,829
+165.4%
0.00%
Q4 2013$589,000
+31.5%
30,834
+12.8%
0.00%
Q3 2013$448,00027,3340.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,184,942$31,784,0004.70%
AWM Investment Company, Inc. 1,562,517$9,578,0001.67%
Opaleye Management Inc. 420,000$2,574,0000.91%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0000.75%
GENERAL AMERICAN INVESTORS CO INC 867,600$5,318,0000.50%
Grandeur Peak Global Advisors, LLC 538,363$3,300,0000.50%
Redmond Asset Management, LLC 55,941$343,0000.16%
WOODSTOCK CORP 88,303$541,0000.10%
CADENCE CAPITAL MANAGEMENT LLC 173,808$1,065,0000.07%
Sheaff Brock Investment Advisors, LLC 71,000$435,0000.06%
View complete list of ARATANA THERAPEUTICS INC shareholders